162 WNT-6 INDUCES THE CHONDROGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS  by Bony, C. et al.
Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256 S79
isolation by a novel method (RIN > 6 = 70%, 260/280: 1.8∼2.0 = 100%,
260/230 > 1.0 = 95% (n=50)) and morphometry calculation by μCT (OA
n=20, non-OA normal n=2), Illumina microarray was performed (OA n=10,
non-OA normal n=2) and real-time quantitative polymerase chain reaction
was executed for data validation (OA n=20, non-OA normal n=2).
Results: A total of 205 transcripts were found be expressed at signiﬁcantly
different level among the regions. Most of these genes related to the
extracellular matrix synthesis, cell proliferation, bone cell differentiation.
These genes might play key roles in breakdown of subchondral bone
homeostasis in OA.
Conclusions: The novel USB RNA isolation methodical approach reported
here not only allows to determine area-speciﬁc gene proﬁles in knee
specimen. In addition, this study also show some genes might play a role
in OA bone remodeling.
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CHARACTERIZATION OF BONE CELLS FROM HEALTHY AND
OSTEOARTHRITIS PATIENTS
G. Lisignoli, C. Manferdini, E. Gabusi, F. Grassi, A. Piacentini, B. Grigolo,
L. Cattini, A. Facchini
Istituto Ortopedico Rizzoli, Bologna, Italy
Human bone cells derived from bone marrow (BM) aspirates or trabecular
bone (TB) tissue have been used for studies of bone biology. However,
an in-vitro characterization of these cells is necessary not only for basic
studies in health and disease but also for cellular therapies for tissue repair.
Bone tissue is often discarded during joint replacement or bone correction
surgery and this tissues could represent a good potential alternative source
of osteoprogenitor cells for tissue engineering purposes. The study aims
to validate the potential of different bone cells obtained from the same
anatomical site. Therefore, we isolated MSCs from BM and osteoblasts (OBs)
from tibia of healthy and OA patients. MSCs and OBs were compared for
growth conditions, cell proliferation, phenotype and osteogenic potential.
MSCs and OBs were grown both in α-MEM and DMEM/F12 medium. We
found that MSCs were able to grow only in α-MEM while OBs could survive
and proliferate in both medium tested. The proliferation of healthy MSC and
OB grown in α-MEM was signiﬁcantly higher than OA MSC and OB, while
no signiﬁcant differences were observed in OB grown in DMEM/F12. Flow
cytometric analysis for CD73, CD90, CD105, CD146, alkaline phosphatase,
bone sialoprotein (BSP) and collagen type I did not show differences among
the groups analysed. The osteogenic potential of MSC and OB grown in
α-MEM were next tested inducing the cells to differentiate along the
osteoblast lineage in osteogenic medium and demonstrating the positive
staining for extracellular calcium deposition at day 28. Real time PCR
analysis demonstrated a decrease expression of alkaline phosphatase and
collagen type I associated with an increase of collagen type XV from Day 0
to day 28, while BSP expression was signiﬁcantly increased only in healthy
MSC and OA OB but not in OA MSC. Osteogenic control experiments were
also performed using MSC from iliac crest. Here, we found a decreased
expression of alkaline phosphatase and collagen type I from day 0 to day
28 and a signiﬁcant increase in collagen type XV and BSP expression. These
data suggest that even if osteogenic differentiation occurs in MSC and OB
from OA patients, OA OB were skewed towards a pattern of expression of
speciﬁc osteogenic markers more similar to that found in canonical BM
MSC.
Cartilage Repair and Mesenchymal Cells
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SMAD2/3 SIGNALING IS CRUCIAL FOR CARTILAGE MAINTENANCE,
WHEREAS SMAD1/5/8 SIGNALING DETERMINES CHONDROCYTE
TERMINAL DIFFERENTIATION
E.N. Blaney Davidson1,2, C.A. Hellingman3, W. Koevoet3, E.L. Vitters1,
W.B. van den Berg1, G.J. van Osch3, P.M. van der Kraan1
1Univ. Med. Ctr. St. Radboud, Nijmegen, Netherlands; 2Leiden Univ. Med. Ctr.,
Leiden, Netherlands; 3Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: In osteoarthritis (OA), chondrocyte behavior seems a recapit-
ulation of the developmental process. Chondrocytes loose their articular
cartilage phenotype and progress into a state highly similar to chondrocyte
hypertrophy, overexpressing MMP13. We have previously shown that dur-
ing OA, the balance between the TGF-beta receptors ALK1 and ALK5 shifts,
favoring the ALK1 receptor. Downstream this leads to a shift from signaling
via Smad2/3 towards Smad1/5/8, thereby favoring the signaling pathway
that is important in terminal differentiation. As a consequence, blocking of
the Smad1/5/8 pathway in differentiating chondrocytes might be a tool to
inhibit chondrocytes terminal differentiation.
We show that Smad1/5/8P expression is correlated with MMP13 expression
in limb formation and in terminally differentiated pellet cultures. More-
over, whereas blocking Smad2/3P halted further chondrogenesis, we show
that blocking the Smad1/5/8 pathway blocked terminal differentiation and
therefore inhibited chondrocyte hypertrophy.
Methods: BMSC were chondrogenically differentiated in pellet culture
in chondrogenic medium including TGF-β2. SB-505124 was added to in-
hibit Smad2/3 phosphorylation, while dorsomorphin was added to inhibit
Smad1/5/8 phosphorylation.
Immunohistochemistry and gene-expression analysis was performed for
markers of chondrogenic and terminal differentiation, as well as for
Smad2/3P and Smad1/5/8P. The ability to mineralize the tissue-engineered
constructs was studied in-vitro by adding 10 mM β-glycerophosphate (BGP)
to the medium.
Results: In pellet cultures of terminally differentiated BMSCs as well as
well as during embryonic limb formation, terminally differentiated chon-
drocytes were positive for both Smad2/3P and Smad1/5/8P. On the other
hand, hyaline-like cartilage that lacks expression of MMP13 and collagen X
did not express Smad1/5/8P, but expressed Smad2/3P.
To investigate whether both pathways were important during onset of
chondrogenesis, SB-505124 or dorsomorphin were added throughout the
culture period. This resulted in lack of collagen II expression, suggest-
ing that both pathways are involved in early chondrogenesis. However,
when the chondrocytes were given the opportunity to ﬁrst differentiate
towards a cartilage phenotype for 14 days and thereafter either Smad2/3
or Smad1/5/8 phosphorylation were blocked until day 35 distinct functions
were demonstrated.
Blocking Smad2/3phosphorylation from day 14-35 resulted in a halt in
collagen II production, whereas blocking Smad1/5/8phosphorylation de-
creased the expression of MMP13, collagen X and alkaline phosphatase
without inhibiting further collagen II production. Blocking Smad1/5/8phos-
phorylationcompletely prevented mineralization (Figure 1).
Figure 1. Alizarine Red staining demonstrating mineralization in control pellets (A), and
no mineralization in pellets treated with dorsomorphin from day 14 on (B).
Conclusions: Our data show that both the Smad2/3 and Smad1/5/8 path-
way are important for initial chondrogenesis in vitro. Blocking Smad2/3
after onset of chondrogenesis halts further collagen type II production
suggesting this pathway is crucial for cartilage maintenance. In contrast,
blocking Smad1/5/8 phosphorylation totally prevents terminal differentia-
tion as the expression of MMP13, collagen X and Alkaline phosphatase are
inhibited.
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WNT-6 INDUCES THE CHONDROGENIC DIFFERENTIATION OF
MESENCHYMAL STEM CELLS
C. Bony, D. Guerit, C. Jorgensen Sr., D. Noel Sr.
Inserm, Montpellier, France
Purpose: Mesenchymal stem cells (MSC) are suitable sources for cell-based
therapies in tissue engineering thanks to their capacities of differentiation
towards several lineages of the skeletal tissue. In particular, their potential
to differentiate into chondrocytes makes them attractive for cartilage re-
pair. However, regeneration of a fully functional and mature tissue will rely
on the use of an optimal combination of scaffold and differentiation factor.
Identiﬁcation of a factor that may induce the chondrocytic lineage and
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maintain the mature chondrocyte phenotype avoiding terminal differentia-
tion towards hypertrophy represents a major issue and is the objective of
this study.
Methods: Bone marrow-derived murine MSCs were induced to differentiate
towards chondrocytes using the micropellet culture technique in presence
of Wnt-6 containing conditioned medium (CM). CM was obtained after
incubation of a chondrogenic medium consisting of DMEM supplemented
with ITS, proline, ascorbic acid and sodium pyruvate for 48h on conﬂuent
NIH-3T3 cells stably transfected to secrete Wnt-6. As controls, CM from
NIH-3T3 cells or BMP-2 containing medium was used. Similar conditions
were used to obtain CM with osteogenic or adipogenic media. After 21 days,
quantitative RT-PCR was performed on total RNA to detect the expression
of markers speciﬁc for each lineage and staining speciﬁc for proteoglycans,
mineralization or lipid droplets was performed. Western blotting with anti-
β-catenin, anti-JNK or anti-PKC antibodies was performed after migration
and transfer on nitrocellulose membranes of 20 μg total proteins extracted
from pellets after a time course exposure to the different CM.
Results: Pellet culture of murine MSCs in presence of NIH-derived CM or
chondrogenic medium alone did not up-regulate the chondrocytic markers.
On the contrary, Wnt-6 containing CM was suﬃcient to induce the differ-
entiation of MSCs into chondrocytes as shown by the induction of collagen
type IIB, aggrecan and COMP and a positive staining for proteoglycans.
The expression levels of the transcripts were lower than those induced by
BMP-2. However, contrary to BMP-2, we observed the lack of induction of
the hypertrophic markers collagen type X and alkaline phosphatase when
MSCs were cultured in Wnt-6 CM. Interestingly, in osteogenic or adipogenic
conditions, MSCs did not up-regulate the markers speciﬁc for osteoblasts or
adipocytes and rather decreased their expression level. The up-regulation
of chondrocytic markers by Wnt-6 was associated with a lack of induction
of the β-catenin or JNK pathways and preliminary results suggest that PKC
signalling may be induced.
Conclusions: Our results suggest that Wnt-6 is one new chondrogenic
factor suﬃcient to speciﬁcally induce the generation of chondrocytes
and inhibiting their terminal differentiation. Preliminary results suggest
that Wnt-6 might induce the PKC-dependent pathway to activate the
chondrocyte-speciﬁc genes.
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CELL TRACKING FOR CARTILAGE REPAIR USING SUPERPARAMAGNETIC
IRON OXIDES: CLINICAL POTENTIAL
G.M. van Buul, G. Kotek, P.A. Wielopolski, E. Farrell, P.K. Bos, H. Weinans,
J.A. Verhaar, G.P. Krestin, M.R. Bernsen, G.J. van Osch
Erasmus MC, Rotterdam, Netherlands
Purpose: Human bone marrow stromal cells (hBMSCs) are experimentally
being used in patients as a cell-based therapy for cartilage repair. To verify
the safety and eﬃcacy of such approaches it is necessary to determine the
fate of these implanted cells. Cell labeling using superparamagnetic iron
oxides (SPIOs) enables non-invasive in vivo cell tracking by MRI, and has
already been used in a clinical setting in various ﬁelds. In this study we de-
scribe a major step towards application of SPIO-labeling for cell tracking in
clinical cell-based cartilage repair approaches. We investigated the safety,
intra-articular MRI traceability and the possibility of SPIO re-uptake of this
cell tracking technique.
Methods: Safety: hBMSCs from three donors were labeled in triplicate
samples with ferumoxides (Endorem®)-protamine sulphate complexes at
doses ranging from 0 - 250 μg iron/ml. After incubation for 24 hours, cell
viability was assessed using a trypan blue exclusion assay. Subsequently,
metabolic cell activity was quantiﬁed using the AlamarBlue® assay up to
seven days after labeling. Chondrogenic capacity of hBMSCs labeled with
100 μg/ml SPIO was evaluated using thionine staining and collagen type II
immunohistochemistry.
Intra-articular imaging: SPIO-labeled hBMSCs (100,000 to 5,000,000 cells)
were injected ex vivo in pig knees, to mimic a clinically relevant sized
model. Furthermore, SPIO-labeled cells (10,000 - 1,000,000 per 75 μl) were
seeded in cartilage defects in vitro. Scanning was performed on a clinical
3.0 T MRI scanner.
SPIO re-uptake: To study possible SPIO re-uptake by synovial cells, viable
and dead GFP-SPIO double-labeled chondrocytes were seeded on human
synovium explants. After co-culturing for ﬁve days, samples were harvested
and analyzed using ﬂuorescence- and light microscopy.
Results: Safety: SPIO labeling resulted in labeling eﬃciencies of ± 95% and
did not impair cell viability or subsequent cell activity at any dose. SPIO-
labeled hBMSCs produced amounts of glycosaminoglycan and collagen type
II comparable to unlabeled control cells.
Intra-articular imaging: All SPIO-labeled cell dosages, both intra-articularly
injected and cells seeded in cartilage defects, were visualized by MRI (Fig.
1). Cell-dose dependent signal voids were observed, and cells could be
clearly differentiated from anatomical structures. SPIO-labeled cells seeded
in cartilage defects could be quantiﬁed using a T2* mapping MRI technique.
SPIO re-uptake: GFP+-SPIO+ cells, indicating originally seeded cells, were
seen in samples containing live cells. GFP--SPIO+ cells, indicating SPIO
re-uptake by synovial cells, were found in samples containing dead cells.
Conclusions: hBMSC labeling with SPIO particles is feasible, without
leading to negative effects on cell viability, subsequent metabolic cell ac-
tivity or chondrogenic differentiation. SPIO-labeled cells can be visualized
intra-articularly by MRI and quantiﬁed when seeded in a cartilage defect.
Although possible SPIO re-uptake by host cells has to be taken into account,
we showed promising results for the use of SPIO labeling for cell tracking
in clinical cartilage repair. This approach provides the extra advantage to
simultaneously track cells and evaluate cartilage repair in one MRI session.
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CHONDROGENIC POTENTIAL OF SUBPOPULATIONS OF CELLS EXPRESSING
MESENCHYMAL STEM CELL MARKERS DERIVED FROM HUMAN SYNOVIAL
MEMBRANES
M.C. Arufe1,2, A. De la Fuente1, S. Díaz1,2, I. Fuentes1,2 , F.J. De Toro1,2,
F.J. Blanco1,3
1Osteoarticular and Aging Res. Lab. Cellular Therapy Unit. Ciber-BBN.
INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain; 2Dept. Med. Area of
Anatomy and Human Embryology. Fac. Hlth.Sci. Univ. of A Coruña, A Coruña,
Spain; 3Cathedra BIOIBERICA of Cell Therapy Univ. of A Coruña, A Coruña,
Spain
Purpose: Synovial membrane mesenchymal stem cells (MSCs) have been
demonstrated to be a good source of cells for the study of cartilage tissue
engineering. Multiple stem cells markers have been found by ﬂow cytom-
etry and immunoﬂuorescence in MSCs from human synovial membrane
pools. In this study we analyzed the chondrogenic potential of subpopula-
tions of MSCs derived from human synovial membranes enriched for CD73,
CD106 and CD271 markers.
Methods: Subpopulations of human synovial membrane MSCs enriched for
CD73, CD106 and CD271 markers were isolated using a cytometry sorter
and characterized by ﬂow cytometry for MSC markers. The expression
of Sox9, Nanog and Runx2 genes by these cells was measured by re-
verse transcriptase-polymerase chain reaction. The chondrogenesis of each
subpopulation was assessed by culturing the cells in a deﬁned medium
to produce spontaneous spheroid formation and differentiation towards
chondrocyte-like cells. The examination of the spheroids by histological
and immunohistochemical analyses for collagen type II (COL2), aggrecan,
collagen type I (COL1), metalloprotease 13 (MMP13) and collagen type
X (COLX) levels were performed to assess their chondrogenesis capacity.
The adipogenesis and osteogenesis potential of each subpopulation was
determined using commercial media; the resulting cells were stained with
oil red O or red alizarin to test the degree of differentiation.
Results: The subpopulations had different proﬁles of cells positive for
the MSC markers CD44, CD69, CD73, CD90 and CD105 and showed dif-
ferent expression levels of the genes Sox9, Nanog, Runx2 involved in
chondrogenesis, undifferentiation and osteoblastogenesis, respectively. Im-
munohistochemical analysis demonstrated that COL1, COL2, COLX, MMP13
and aggrecan were expressed in the spheroids as soon as 14 days of culture.
The CD271+ subpopulation expressed the highest levels of COL2 staining
